<div id="readability-page-1"><p>Nearwater Capital Markets Ltd lowered its stake in shares of  Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 54.6% during the first quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The institutional investor  owned 47,579 shares of the medical equipment provider's stock after selling 57,326 shares during the period. Nearwater Capital Markets Ltd's holdings in Intuitive Surgical were worth $23,564,000 at the end of the most recent quarter.</p><ul><li>3 Robotics Stocks at the Heart of the Robotics Revolution</li></ul><p>A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Brighton Jones LLC increased its holdings in shares of  Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter.  Bank Pictet &amp; Cie Europe AG increased its holdings in shares of  Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet &amp; Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after acquiring an additional 883 shares during the last quarter.  Cary Street Partners Financial LLC acquired a new position in shares of  Intuitive Surgical during the 4th quarter worth approximately $220,000.  Cetera Investment Advisers increased its holdings in shares of  Intuitive Surgical by 5.4% during the 4th quarter. Cetera Investment Advisers now owns 67,202 shares of the medical equipment provider's stock worth $35,077,000 after acquiring an additional 3,440 shares during the last quarter.  Finally, Crestline Management LP acquired a new position in shares of  Intuitive Surgical during the 4th quarter worth approximately $1,456,000. Institutional investors own  83.64% of the company's stock. </p><div><p><span></span><span>Get <strong>Intuitive Surgical</strong> alerts:</span></p></div><h2>Intuitive Surgical Stock Performance</h2><p>ISRG opened at $454.52 on Friday. The firm has a market cap of $162.94 billion, a P/E ratio of 63.39, a price-to-earnings-growth ratio of 4.62 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The business's fifty day moving average is $495.33 and its 200-day moving average is $514.32. </p><ul><li> Intuitive Surgical Crushes Q2 Expectations, So Why No Rally?</li></ul><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.78 EPS.  On average, research analysts predict that  Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year. </p><h2>Insider Transactions at Intuitive Surgical</h2><p>In other news, Director Amy L. Ladd sold 335 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director directly owned 739 shares of the company's stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by corporate insiders. </p><h2>Analysts Set New Price Targets</h2><ul><li>5 Robotics Stocks to Buy for the Future of Automation</li></ul><p>A number of research analysts recently weighed in on the company. Evercore ISI boosted their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an &#34;in-line&#34; rating in a report on Tuesday, July 8th. Piper Sandler  reissued an &#34;overweight&#34; rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Citigroup  reissued a &#34;buy&#34; rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Erste Group Bank  reaffirmed a &#34;hold&#34; rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Truist Financial upped their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned  a Hold rating and one  has assigned  a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $595.95.</p><p><b>Read Our Latest Analysis on ISRG</b></p><h2>Intuitive Surgical Company Profile</h2> (Free Report)<p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Intuitive Surgical</li><li>Insider Trading - What You Need to Know</li><li>Why Marvell’s 19% Drop Could Be a Big Buy-the-Dip Opportunity</li><li>Bank Stocks - Best Bank Stocks to Invest In</li><li>Daqo New Energy: Solar Monopoly Launches $100M Buyback</li><li>Most active stocks: Dollar volume vs share volume</li><li>Affirm Crushes Earnings Expectations, Turns Bears into Believers</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2><p>Before you consider Intuitive Surgical, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ISRG

<p>Nearwater Capital Markets Ltd has reduced its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 54.6%, selling 57,326 shares in the first quarter. After the sale, it holds 47,579 shares valued at approximately $23.56 million. Other institutional investors have also adjusted their positions in ISRG, with Brighton Jones LLC increasing its holdings by 24.9%. Intuitive Surgical's stock opened at $454.52, with a market cap of $162.94 billion and a P/E ratio of 63.39. The company reported strong Q2 earnings, exceeding estimates with $2.19 EPS and $2.44 billion in revenue.</p>

Nearwater Capital Markets Ltd Sells 57,326 Shares of Intuitive Surgical, Inc. $ISRG